Comparison of two protocols for the generation of iPSC-derived human astrocytes.

Patrycja MulicaCarmen VenegasZied LandoulsiKatja BadanjakSylvie DelcambreMaria TziortziouSoraya HezzazJenny GhelfiSemra SmajicJens SchwambornRejko KrügerPaul AntonyPatrick MayEnrico GlaabAnne GrünewaldSandro L Pereira

Published in: Biological procedures online (2023)

Overall, our analyses highlight the need to consider the advantages and disadvantages of a given differentiation protocol, when designing functional or drug discovery studies involving iPSC-derived astrocytes.

Keyphrases

drug discovery
induced pluripotent stem cells
endothelial cells
randomized controlled trial
pluripotent stem cells
case control